BioAge Labs (BIOA) Other Non-Current Liabilities (2023 - 2026)

BioAge Labs has disclosed Other Non-Current Liabilities across 4 years of filings, most recently posting $477000.0 for Q1 2026.

• Other Non-Current Liabilities for Q1 2026 came in at $477000.0, up 391.75% year-over-year; the trailing twelve-month figure through Mar 2026 was $477000.0 (up 391.75% YoY), and the FY2025 annual result was $370000.0, up 137.18% from the prior year.
• Other Non-Current Liabilities came in at $477000.0 for Q1 2026 at BioAge Labs, up from $370000.0 in the prior quarter.
• In the past five years, Other Non-Current Liabilities ranged from a high of $613000.0 in Q3 2024 to a low of $97000.0 in Q1 2025.
• The 4-year median for Other Non-Current Liabilities is $192500.0 (2023), against an average of $275000.0.
• Across the five-year window, Other Non-Current Liabilities plunged 75.53% in 2025 and surged 391.75% in 2026, its largest moves.
• BioAge Labs' Other Non-Current Liabilities stood at $229000.0 in 2023, then slumped by 31.88% to $156000.0 in 2024, then soared by 137.18% to $370000.0 in 2025, then grew by 28.92% to $477000.0 in 2026.
• The last three Other Non-Current Liabilities figures came in at $477000.0 (Q1 2026), $370000.0 (Q4 2025), and $150000.0 (Q3 2025), per Business Quant data.